Smart injection technology developer Common Sensing secured $6.6m in a round featuring Haselmeier and Royal Philips.

US-based injectable medicine technology developer Common Sensing has completed a $6.6m series A round that included drug injection device maker Haselmeier and healthcare technology manufacturer Royal Philips.

Healthcare technology and services-focused venture capital fund Waterline Ventures led the round, which also featured VC firm New World Health.

Founded in 2012, Common Sensing has created a product called Gocap that converts injector pens into smart, connected injectors. The technology could be used to enhance the delivery of substances such as insulin,…